跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
Authorized
STANDARD
WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2419fff9b8c37350
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
2419fff9b8c37350
Drug Approval Canada Name
WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
Product Name
WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE
Status
Dormant
Status Date
2019-08-05
Original Market Date
2016-12-23
Din
02453703
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Narcotic (CDSA I)
Ahfs
28:08.92
Atc Original
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Atc Name
n 02 be 51
Aig Number
0311391002
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
ACETAMINOPHEN
300 MG
CAFFEINE
15 MG
CODEINE PHOSPHATE
8 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2419fff9b8c37350
Type
Standard
Back to Health Canada Approvals